September 29, 2023
cancer
cancer
The FDA approved Keytruda for a range of cancers with a common biomarker. At right, Dr. Thomas George, associate director of clinical investigation at University of Florida Health Cancer Center.

Cancer Care

Wider Approval

The FDA takes a broader approach to approving drug therapy.

Amy Martinez | 2/27/2018

Historically, the FDA has approved cancer drugs based on a particular cancer’s location in the body, but that may be changing.

Last year, the FDA said Keytruda, a new immunotherapy drug by Merck, could be used to treat all cancers that share a genetic abnormality called mismatch repair (MMR) deficiency. It was the first time the FDA approved a cancer drug based on a common biomarker rather than the cancer type — lung vs. breast, for example. Keytruda itself previously had been approved for patients with metastatic lung, neck and skin cancers.

The immunotherapy targets proteins on T-cells that prevent a patient’s immune system from recognizing and attacking cancer cells. By blocking these proteins, Keytruda aims to increase the im- mune system’s ability to home in on cancer cells without harming normal, healthy tissue. About 40% of cancer patients who received Keytruda in clinical trials saw their tumors shrink or disappear.

Doctors estimate that 4% of all cancers are MMR deficient, potentially making 60,000 patients a year eligible for the infused drug, which costs about $150,000 a year.

“At some point in the future — and it may be past my lifetime — if the immune system can be harnessed safely and effectively, there should be no need for surgery, radiation and traditional chemotherapy,” says Dr. Thomas George, associate director of clinical investigation at University of Florida Health Cancer Center. “The cancer should be permanently destroyed by a patient’s own immune system.”

 

See other stories from Florida Trend's March issue.

Get Florida Trend's March magazine – print or digital. Select from these options:

EXISTING
DIGITAL
SUBSCRIBERS

Access Article Now!

DIGITAL
SINGLE
ISSUE

Get a single DIGITAL copy of this issue

$4.95

PRINT
SINGLE
ISSUE

Get a single PRINT copy of this issue

$4.95
plus $3 postage & handling

PRINT SUBSCRIPTION

One year in PRINT

$14.98*
plus a FREE gift!

DIGITAL SUBSCRIPTION

One year DIGITAL

$14.98*
plus a FREE gift!

ALL ACCESS SUBSCRIPTION

One year Combo
PRINT + DIGITAL

$24.95*
plus a FREE gift!


CURRENT  PRINT  SUBSCRIBERS

If you are already a print subscriber,
ADD DIGITAL EDITION ACCESS
to your existing subscription here!
(or call our office at 727-892-2643)

* offer valid for new subscribers only

Tags: Government/Politics & Law, Healthcare, Life Sciences, Research & Development, Technology/Innovation, Cancer Care, Economic Backbone

Florida Business News

  • Florida’s population boom drives bigger hurricane losses, despite tougher building codes

    Florida leads the nation in strict building codes, and the decades of hard work have paid off in the increasing number of homes and buildings that survive each time a hurricane slashes the state. But all those hard-won gains have been undermined by the explosion of growth along the coast.

  • Business BeatBusiness Beat - Week of September 29th

    Get top news-to-know with Florida Trend's headline-focused video news brief, hosted by digital content specialist Aimée Alexander.

  • Enterprise Florida exiting

    The doors are ready to close on Enterprise Florida, the business-recruitment agency long targeted by state House leaders.

  • Seeking protection

    Three activist groups served notice to the U.S. Fish and Wildlife Service that they intend to sue to force the agency to invoke Endangered Species Act protection for the ghost orchid.

  • State jobless claims decrease

    An estimated 5,155 first-time jobless claims were filed in Florida last week, a decrease from the previous week and below the average for the year.

Florida News Releases

Florida Trend Video Pick

Radioactive roads? Florida has yet to submit application to EPA to start testing
Radioactive roads? Florida has yet to submit application to EPA to start testing

It appears no steps have been taken to begin testing whether slightly radioactive waste from fertilizer production can be repurposed for Florida road construction projects.

Video Picks | Viewpoints@FloridaTrend

Ballot Box

Do you believe that home values in Florida have finally peaked?

  • Absolutely!
  • No way!
  • The jury's still out...
  • Other (Let us know in the comment section below)

See Results

Florida Trend Media Company
490 1st Ave S
St Petersburg, FL 33701
727.821.5800

© Copyright 2023 Trend Magazines Inc. All rights reserved.